SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

eBay, Inc. is a commerce company, whose platforms include an online marketplace and its localized counterparts, including off-platform businesses in Japan, as well as eBay’s suite of mobile apps. It offers a platform for various product categories, including parts and accessories, collectibles, fashion, electronics, and home & garden. eBay generates revenue mainly through fees from sales, payment processing, and advertising. The company was founded by Pierre Morad Omidyar in September 1995 and is headquartered in San Jose, CA.

EBay Inc.

eBay Inc

GameStop is trending following an unsolicited fifty-six billion dollar acquisition bid for eBay, a move that has sparked intense debate among investors regarding the viability of such a highly leveraged acquisition. Community members are actively split, with some viewing the move as a visionary corporate chess play, while critics, including high-profile investors, have voiced significant concerns over the proposed debt levels and potential share dilution.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is attracting significant institutional accumulation as investors position themselves ahead of major clinical readouts, including the upcoming 52-week data for its sonelokimab program. The community is focused on this data and the Goldman Sachs conference, with many speculating that these events could serve as the catalyst for an acquisition or a significant upward repricing.

Procter & Gamble Co. engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances. The Health Care segment includes oral care products like toothbrushes, toothpaste, and personal health care such as gastrointestinal, rapid diagnostics, respiratory, and vitamins, minerals, and supplements. The Fabric and Home care segment consists of fabric enhancers, laundry additives and detergents, and air, dish, and surface care. The Baby, Feminine and Family Care segment sells baby wipes, diapers, and pants, adult incontinence, feminine care, paper towels, tissues, and toilet paper. The company was founded by William Procter and James Gamble in 1837 and is headquartered in Cincinnati, OH.

Procter & Gamble Co.

Procter & Gamble is seeing significant investor interest as the community navigates a rotation into defensive value plays amidst broader market volatility. Discussions are heavily focused on the stock's role as a dividend-heavy ballast for long-term portfolios, while technical traders are closely monitoring key support levels and potential reversal signals for this consumer staples giant.

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

Fannie Mae $FNMA is trending as investors react to presidential comments regarding a potential IPO and a trillion-dollar valuation, fueling intense speculation about an end to the long-standing FHFA conservatorship. The community remains deeply divided between long-term holders anticipating a historic release and skeptics warning of potential market manipulation and delays.

Bitwise XRP ETF - Common Shares Of Beneficial Interest

Bitwise XRP ETF

XRP is trending as institutional interest remains high, highlighted by the strong performance of Bitwise's XRP ETF and increasing institutional adoption of the XRP Ledger for real-world asset tokenization. Community sentiment is deeply split, with investors actively debating the potential impact of ongoing regulatory developments like the Clarity Act against concerns regarding Ripple's circulating supply and long-term price suppression.

Oatly Group AB is a holding company, which focuses on developing expertise around oats, a global power crop with inherent properties suited for sustainability and human health. It operates through the following geographical segments: Europe & International, North America and Greater China. The company was founded by Björn Öste in 1994 and is headquartered in Malmö, Sweden.

Oatly Group AB - ADR

Oatly Group

Oatly is experiencing significant investor attention driven by speculation surrounding a potential strategic carve-out of its China operations and the company's recent shift toward profitable growth. Community discussion is heavily focused on the stock's low valuation relative to its brand reach, the anticipation of new product launches in the US, and the belief that JAB Holding's increased stake signals a long-term turnaround or acquisition play.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is experiencing a sustained rally driven by high anticipation for the upcoming R2 SUV deliveries and momentum from its software licensing strategies. While some investors remain cautious about the company's path to profitability and broader market volatility, the community is actively debating the stock's potential for a breakout as short interest remains a focal point of the conversation.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is experiencing extreme volatility as community members debate whether the assets rapid, leverage-driven ascent is a sustainable momentum play or a dangerous bubble tied to the South Korean semiconductor cycle. Traders are actively tracking shifts in the KOSPI index and local corporate news, weighing the risk of massive overnight swings against the potential for continued gains from the high-bandwidth memory shortage.

ProShares Trust II - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

ProShares Ultra Bloomberg Crude Oil is trending as traders debate the impact of escalating U.S.-Iran geopolitical tensions on crude supplies and the potential for a peace deal to disrupt market volatility. The community remains deeply divided, with discussions centered on whether to buy the dip during intermittent ceasefire negotiations or to short the instrument, citing concerns over leverage decay and the long-term sustainability of the current price rally.

Direxion Shares ETF Trust - Direxion Daily Gold Miners Index Bull 2X ETF

Direxion Daily Gold Miners Index Bull 2X Shares

The Direxion Daily Gold Miners Index Bull 2X Shares ($NUGT) is trending as traders closely track volatile gold prices, surging industrial demand for metals, and ongoing global economic uncertainty. Community discussion is polarized between bullish investors anticipating further upside from central bank gold accumulation and bearish voices cautioning that the asset class is historically overbought and potentially vulnerable to a sharp correction.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Innoviva to Participate in Upcoming Investor Conferences

Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified biopharmaceutical company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets...

Innoviva Stock Is Up Just 10% This Past Year. Here's Why a Fund Bought $2.5 Million More

Key PointsDauntless Investment Group bought 116,863 shares of Innoviva in an estimated trade of $2.52 million last quarter...

Innoviva (INVA) Tops Q1 Earnings Estimates

Innoviva (INVA) delivered earnings and revenue surprises of +3.53% and -1.83%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Innoviva Reports First Quarter 2026 Financial Results; Highlights Recent Company Progress

Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified biopharmaceutical company with a core royalties portfolio, a leading critical care and infectious disease platform known as...

Pfizer (PFE) Q1 Earnings and Revenues Top Estimates

Pfizer (PFE) delivered earnings and revenue surprises of +5.63% and +4.56%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Jennison Associates LLC Buys New Shares in Innoviva, Inc. $INVA

Jennison Associates LLC purchased a new position in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 46,403 shares of the biotechnology company's stoc...

Merck (MRK) Reports Q1 Loss, Tops Revenue Estimates

Merck (MRK) delivered earnings and revenue surprises of +15.47% and +2.44%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Innoviva (INVA) to Release Quarterly Earnings on Wednesday

Innoviva (NASDAQ:INVA) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 6. (View Earnings Report at...

Innoviva, Inc. (NASDAQ:INVA) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of Innoviva, Inc. (NASDAQ:INVA - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the seven brokerages that are covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and fiv...

Innoviva (NASDAQ:INVA) Shares Cross Above 200-Day Moving Average   - Time to Sell?

Innoviva (NASDAQ:INVA) Shares Cross Above 200-Day Moving Average - Here's Why...

Innoviva, Inc. engages in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Burlingame, CA.

Current Price	$22.52
Prev Close	$22.16
Open	$22.46
Dividend Yield	0.00%
50-Day Moving Average	$22.90
Beta	0.30
Avg. Volume	805,323.15
PE Ratio	3.74

52-Week High	$25.15
52-Week Low	$16.52
Market Capitalization	$1.64B
EPS (Annual)	$3.30
Price to Book	1.24
Revenue Per Employee	$2.67M

INVAInnoviva Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest INVA News